Terms: = Bone cancer AND LDH AND Staging
43 results:
1. Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.
Abdrabou AK; Al Sharif F; El Fakih R; Zahrani HA; Al Yamany R; Saleh M; Alhayli S; Al Somali Z; Alotaibi A; AlShaibani A; Deeba F; Asif M; Ahmed SAOA; Al Fraih F; Shaheen M; Alahmari A; Rasheed W; Chaudhri NA; Al Mohareb F; Aljurf M; Hanbali A
Ann Saudi Med; 2024; 44(2):93-103. PubMed ID: 38615184
[TBL] [Abstract] [Full Text] [Related]
2. Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
3. [Expression level of Wilms' tumor 1 gene and its correlation with clinical features in patients with myeloproliferative neoplasms].
Liu C; Wu SY; Zhang AB; Luo P; Zhou Y; Liu Y; Zuo XL
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3658-3664. PubMed ID: 38018065
[No Abstract] [Full Text] [Related]
4. Laboratory Evaluation and Pathological Features of bone Marrow Metastasis in Non-haematological Malignancies.
Rana NA; Mahmood A; Robert HM; Zahir S; Asghar MB; Riaz S
J Coll Physicians Surg Pak; 2022 Oct; 32(10):1367-1369. PubMed ID: 36205291
[TBL] [Abstract] [Full Text] [Related]
5. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract] [Full Text] [Related]
7. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
8. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract] [Full Text] [Related]
9. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
10. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.
Thacker N; Bakhshi S; Chinnaswamy G; Vora T; Prasad M; Bansal D; Agarwala S; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Dhaliwal RS; Arora B
Indian J Pediatr; 2017 May; 84(5):382-392. PubMed ID: 28378140
[TBL] [Abstract] [Full Text] [Related]
11. [Effect of Rigorous staging at the First Diagnosis on Prognosis of Patients with Follicular Lymphoma].
Wang L; Yan B; Yu Y; Wang YF; Yang HL; Zhao HF; Wang XF; Wu XX; DA WM; Li SX; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):126-132. PubMed ID: 28245388
[TBL] [Abstract] [Full Text] [Related]
12. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
[TBL] [Abstract] [Full Text] [Related]
13. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
[TBL] [Abstract] [Full Text] [Related]
14. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract] [Full Text] [Related]
15. Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients.
Durnali A; Alkis N; Cangur S; Yukruk FA; Inal A; Tokluoglu S; Seker MM; Bal O; Akman T; Inanc M; Isikdogan A; Demirci A; Helvaci K; Oksuzoglu B
Med Oncol; 2013; 30(3):624. PubMed ID: 23749307
[TBL] [Abstract] [Full Text] [Related]
17. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract] [Full Text] [Related]
18. Cyclin Dl expression in B-cell non Hodgkin lymphoma.
Aref S; Mossad Y; El-Khodary T; Awad M; El-Shahat E
Hematology; 2006 Oct; 11(5):365-70. PubMed ID: 17607588
[TBL] [Abstract] [Full Text] [Related]
19. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
[TBL] [Abstract] [Full Text] [Related]
20. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
[TBL] [Abstract] [Full Text] [Related]
[Next]
